Information Provided By: 
Fly News Breaks for December 18, 2015
MGLN
Dec 18, 2015 | 06:31 EDT
Jefferies analyst David Styblo says shares of Magellan Health are still undervalued despite the $9 rally this week following the company's 2016 guidance call. Magellan is exceeding expectations and negative sentiment on the Healthcare segment is abating, Styblo tells investors in a research note titled "Stock Has More Room To Run." He raised his price target for the shares to $73 from $67 and keeps a Buy rating on the name.
News For MGLN From the Last 2 Days
There are no results for your query MGLN
